Summit Therapeutics nears a 2026 FDA decision for ivonescimab with $710M cash and Akesobio catalysts. Find out why SMMT stock is upgraded to hold.
The real “commercial launch” happens years before launch preparation officially begins. Once Phase III begins, your evidence ...
Temu, the low price shopping app that has expanded quickly across multiple regions, is now facing a high profile dispute in Argentina with Mercado ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果